Murphy T, Mason JM, Leber B, Bray MR, et al. Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms. Leukemia 2023 Dec 19. doi: 10.1038/s41375-023-02110.
PMID: 38114624